Levolta Pharmaceuticals
Surpassing current treatment barriers by developing products with an enhanced therapeutic index that drive customer value.
Product Pipeline
Our portfolio consists of early-stage small molecules and late-stage novel combinations, ranging from pre-clinical development through phase III.
- VOLT01
- VOLT02
- SYK
- TNF Oral
Phases of Development
